| Name | Title | Contact Details |
|---|
Moss is a Belfast, ME-based company in the Business Services sector.
Source1 Compliance is a Cortland, NY-based company in the Business Services sector.
Actus Nutrition, formerly known as Milk Specialties Global, is a prominent manufacturer of nutritional ingredients for the health and wellness, performance nutrition, and functional food sectors. Established in 1949, the company has rebranded to reflect its growth and market opportunities. Actus Nutrition operates as a vertically integrated manufacturer, providing a variety of products including proteins, caseins, and other food ingredients. They also offer private label solutions for markets such as sports nutrition, healthy snacking, and breakfast cereals. The company features a strong research and development team that creates customizable formulations and flavorings for clients. Actus Nutrition exports its products to over 45 countries, supported by a robust logistical network. Their diverse product portfolio includes whey protein concentrates, isolates, and functional ingredients like lactoferrin and milk fat globule membrane. Additionally, Actus Nutrition is the largest milk replacer manufacturer in North America, catering to the nutritional needs of various animal species. With approximately $1.5 billion in annual revenues, Actus Nutrition operates 12 manufacturing facilities across the United States.
Akridge Co is one of the leading providers in Business Services. It is based in Washington, DC. To find more information about Akridge Co, please visit www.akridge.com.
Polarean is a revenue-generating medical imaging technology company revolutionizing pulmonary medicine through direct visualization of lung function by introducing the power and safety of MRI to the respiratory healthcare community. This community is in desperate need of modern solutions to accurately assess lung function. The Company strives to optimize lung health and prevent avoidable loss by illuminating hidden disease, addressing the global unmet medical needs of more than 500 million patients worldwide suffering from chronic respiratory disease. Polarean is a leader in the field of hyperpolarization science and has successfully developed the first and only hyperpolarized Xenon MRI inhaled contrast agent, XENOVIEW™, which is now FDA-approved in the United States. Polarean is dedicated to researching, developing, and commercializing innovative imaging solutions with its noninvasive and radiation-free pulmonary functional MRI platform. This comprehensive drug-device platform encompasses the proprietary Xenon gas blend, gas hyperpolarization system, as well as software and accessories, facilitating fully integrated modern respiratory imaging operations. Founded in 2012, with offices in Durham, NC, and London, United Kingdom, Polarean is committed to increasing global awareness of and broad access to its XENOVIEW MRI technology platform. For the latest news and information about Polarean, please visit www.polarean.com.